Search Page

1

Cite

Share

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.

De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ. De Marzo AM, et al. Prostate. 1998 Feb 15;34(3):162-8. doi: 10.1002/(sici)1097-0045(19980215)34:3<162::aid-pros2>3.0.co;2-k. Prostate. 1998. PMID: 9492843

Cite

Share

2

Cite

Share

Extensive squamous cell carcinoma in situ of the bladder masking deeply invasive disease.

Halachmi S, De Marzo AM, Linn JF, Epstein JI, Schoenberg MP. Halachmi S, et al. Among authors: de marzo am. J Urol. 1998 Jan;159(1):203. doi: 10.1016/s0022-5347(01)64060-6. J Urol. 1998. PMID: 9400476 No abstract available.

Cite

Share

3

Cite

Share

Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

De Marzo AM, Meeker AK, Epstein JI, Coffey DS. De Marzo AM, et al. Am J Pathol. 1998 Sep;153(3):911-9. doi: 10.1016/S0002-9440(10)65632-5. Am J Pathol. 1998. PMID: 9736039 Free PMC article.

Cite

Share

4

Cite

Share

Stem cell features of benign and malignant prostate epithelial cells.

De Marzo AM, Nelson WG, Meeker AK, Coffey DS. De Marzo AM, et al. J Urol. 1998 Dec;160(6 Pt 2):2381-92. doi: 10.1097/00005392-199812020-00004. J Urol. 1998. PMID: 9817389 Review.

Cite

Share

5

Cite

Share

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.

De Marzo AM, Coffey DS, Nelson WG. De Marzo AM, et al. Urology. 1999 Mar;53(3 Suppl 3a):29-39; discussion 39-42. doi: 10.1016/s0090-4295(98)00536-6. Urology. 1999. PMID: 10094098 Review.

Cite

Share

6

Cite

Share

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.

De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI. De Marzo AM, et al. Urology. 1999 Apr;53(4):707-13. doi: 10.1016/s0090-4295(98)00577-9. Urology. 1999. PMID: 10197845

Cite

Share

7

Cite

Share

Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.

De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG. De Marzo AM, et al. Cancer Res. 1999 Aug 15;59(16):3855-60. Cancer Res. 1999. PMID: 10463569

Cite

Share

8

Cite

Share

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG. Simons JW, et al. Cancer Res. 1999 Oct 15;59(20):5160-8. Cancer Res. 1999. PMID: 10537292 Clinical Trial.

Cite

Share

9

Cite

Share

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Zhong H, et al. Among authors: de marzo am. Cancer Res. 1999 Nov 15;59(22):5830-5. Cancer Res. 1999. PMID: 10582706

Cite

Share

10

Cite

Share

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

De Marzo AM, Marchi VL, Epstein JI, Nelson WG. De Marzo AM, et al. Am J Pathol. 1999 Dec;155(6):1985-92. doi: 10.1016/S0002-9440(10)65517-4. Am J Pathol. 1999. PMID: 10595928 Free PMC article.

Focal prostatic atrophy, which is associated with chronic inflammation, is highly proliferative (Ruska et al, Am J Surg Pathol 1998, 22:1073-1077); thus the focus of this study was to more fully characterize the phenotype of the atrophic cells to assess the feasibility of …

Focal prostatic atrophy, which is associated with chronic inflammation, is highly proliferative (Ruska et al, Am J Surg Pathol 1998, …

Cite

Share